{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:19:23Z","timestamp":1788895163807,"version":"build-2803163510"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T00:00:00Z","timestamp":1462838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003958","name":"Stichting voor de Technische Wetenschappen","doi-asserted-by":"publisher","award":["NanoNextNL 03D.11"],"award-info":[{"award-number":["NanoNextNL 03D.11"]}],"id":[{"id":"10.13039\/501100003958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013918","name":"Stichting Innovatie Alliantie","doi-asserted-by":"crossref","award":["RAAK PRO-2-001 NAT-TEST"],"award-info":[{"award-number":["RAAK PRO-2-001 NAT-TEST"]}],"id":[{"id":"10.13039\/501100013918","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155325","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T17:29:26Z","timestamp":1462901366000},"page":"e0155325","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Head-to-Head Comparison of Anti-Inflammatory Performance of Known Natural Products In Vitro"],"prefix":"10.1371","volume":"11","author":[{"given":"Iris E.","family":"Allijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan F. C.","family":"Vaessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda C.","family":"Quarles van Ufford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees J.","family":"Beukelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno P. J.","family":"de Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond M.","family":"Schiffelers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,10]]},"reference":[{"issue":"7203","key":"ref1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"R Medzhitov","year":"2008","journal-title":"Nature [Internet]"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-13-2322","article-title":"Inflammation amplifier, a new paradigm in cancer biology","volume":"74","author":"T Atsumi","year":"2014","journal-title":"Cancer Res [Internet]"},{"key":"ref3","unstructured":"cellsignal.com. NF- k B Signaling [Internet]. 2014. p. 2014. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cellsignal.com\/common\/content\/content.jsp?id=pathways-nfkb\" xlink:type=\"simple\">http:\/\/www.cellsignal.com\/common\/content\/content.jsp?id=pathways-nfkb<\/ext-link>"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"MS Hayden","year":"2008","journal-title":"Cell [Internet]"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10059-011-0276-3","article-title":"Regulation of reactive oxygen species generation in cell signaling [Internet]","author":"YS Bae","year":"2011","journal-title":"Molecules and Cells"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.semcancer.2013.05.003","article-title":"The structural network of inflammation and cancer: merits and challenges","volume":"23","author":"E Guven Maiorov","year":"2013","journal-title":"Semin Cancer Biol [Internet]. Elsevier Ltd"},{"key":"ref7","unstructured":"cellsignal.com. Jak \/ Stat Signaling : IL-6 Receptor Family [Internet]. 2014. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cellsignal.com\/common\/content\/content.jsp?id=pathways-il6\" xlink:type=\"simple\">http:\/\/www.cellsignal.com\/common\/content\/content.jsp?id=pathways-il6<\/ext-link>"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"MF Neurath","year":"2011","journal-title":"Cytokine Growth Factor Rev [Internet]. Elsevier Ltd"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"S Rose-John","year":"2012","journal-title":"Int J Biol Sci [Internet]"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/Jak\/stat pathway in human malignancies","volume":"30","author":"P Sansone","year":"2012","journal-title":"J Clin Oncol [Internet]"},{"issue":"21","key":"ref11","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"DJJ Waugh","year":"2008","journal-title":"Clin Cancer Res [Internet]"},{"issue":"1","key":"ref12","first-page":"117","article-title":"The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer","volume":"1825","author":"H Verbeke","year":"2012","journal-title":"Biochim Biophys Acta [Internet]"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"W Dr\u00f6ge","year":"2002","journal-title":"Physiol Rev [Internet]"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.thromres.2011.12.002","article-title":"Platelet oxidative stress and thrombosis","volume":"129","author":"F Violi","year":"2012","journal-title":"Thromb Res [Internet]. Elsevier Ltd"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ijlh.12084","article-title":"Platelets: bridging hemostasis, inflammation, and immunity","volume":"35","author":"CN Jenne","year":"2013","journal-title":"Int J Lab Hematol [Internet]"},{"issue":"11","key":"ref16","first-page":"1041","article-title":"Current concepts in glucocorticoid resistance","volume":"77","author":"N Yang","year":"2012","journal-title":"Steroids [Internet]. Elsevier Inc."},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"PJ Barnes","year":"1998","journal-title":"Clin Sci (Lond) [Internet]"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: current and future directions","volume":"163","author":"PJ Barnes","year":"2011","journal-title":"Br J Pharmacol [Internet]"},{"issue":"2","key":"ref19","first-page":"203","article-title":"Steroids: Pharmacology, Complications, and Practice Delivery Issues","volume":"14","author":"W Ericson-Neilsen","year":"2014","journal-title":"Ochsner J [Internet]"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-2133.2007.07950.x","article-title":"Corticosteroid-induced clinical adverse events: Frequency, risk factors and patient\u2019s opinion","volume":"157","author":"L Fardet","year":"2007","journal-title":"Br J Dermatol [Internet]"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/med.20156","article-title":"Recent developments in anti-inflammatory natural products","volume":"29","author":"R Gautam","year":"2009","journal-title":"Med Res Rev [Internet]"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.1007\/BF02854894","article-title":"Drug discovery from natural sources","volume":"8","author":"Y-W Chin","year":"2006","journal-title":"AAPS J [Internet]"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/anie.201000044","article-title":"Plant polyphenols: chemical properties, biological activities, and synthesis","volume":"50","author":"S Quideau","year":"2011","journal-title":"Angew Chem Int Ed Engl [Internet]"},{"issue":"5747","key":"ref24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1126\/science.1116364","article-title":"Chemistry. The renaissance of natural products as drug candidates","volume":"310","author":"I Paterson","year":"2005","journal-title":"Science [Internet]"},{"issue":"1\u20132","key":"ref25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0027-5107(85)90109-5","article-title":"Detection and chemical identification of natural bio-antimutagens. A case of the green tea factor","volume":"150","author":"T Kada","year":"1985","journal-title":"Mutat Res"},{"issue":"8","key":"ref26","first-page":"307","article-title":"Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis","volume":"93","author":"S Riegsecker","year":"2013","journal-title":"Life Sci [Internet]. Elsevier Inc."},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0028-1097869","article-title":"A review on the chemical and pharmacological aspects of genus Berberis","volume":"28","author":"M Ikram","year":"1975","journal-title":"Planta Med"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/jpet.107.128017","article-title":"Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions","volume":"323","author":"GC Pereira","year":"2007","journal-title":"J Pharmacol Exp Ther [Internet]"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"289264","DOI":"10.1155\/2014\/289264","article-title":"Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus","volume":"2014","author":"Z Li","year":"2014","journal-title":"Evid Based Complement Alternat Med [Internet]"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3835(85)90159-4","article-title":"Potential anticancer activity of turmeric (Curcuma longa)","volume":"29","author":"R Kuttan","year":"1985","journal-title":"Cancer Lett [Internet]"},{"issue":"2\u20133","key":"ref31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(01)01516-3","article-title":"Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils","volume":"433","author":"E Van den Worm","year":"2001","journal-title":"Eur J Pharmacol [Internet]"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"106507","DOI":"10.1155\/2008\/106507","article-title":"Apocynin: molecular aptitudes","volume":"2008","author":"J Stefanska","year":"2008","journal-title":"Mediators Inflamm [Internet]"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00011-007-7190-3","article-title":"A genome-wide microarray analysis reveals anti-inflammatory target genes of paeonol in macrophages","volume":"57","author":"H Huang","year":"2008","journal-title":"Inflamm Res [Internet]"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/fcp.12019","article-title":"Paeonol suppresses lipopolysaccharide-induced inflammatory cytokines in macrophage cells and protects mice from lethal endotoxin shock","volume":"28","author":"N Chen","year":"2014","journal-title":"Fundam Clin Pharmacol [Internet]"},{"issue":"2","key":"ref35","first-page":"e53","article-title":"Pterostilbene and cancer: current review","volume":"173","author":"D McCormack","year":"2012","journal-title":"J Surg Res [Internet]. Elsevier Inc"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/jf304487v","article-title":"The inhibitory effect of pterostilbene on inflammatory responses during the interaction of 3T3-L1 adipocytes and RAW 264.7 macrophages","volume":"61","author":"C-LL Hsu","year":"2013","journal-title":"J Agric Food Chem [Internet]"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrd1112","article-title":"Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors","volume":"2","author":"J a Tobert","year":"2003","journal-title":"Nat Rev Drug Discov [Internet]"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrneph.2011.62","article-title":"Statins, inflammation and kidney disease","volume":"7","author":"V Krane","year":"2011","journal-title":"Nat Rev Nephrol [Internet]. Nature Publishing Group"},{"key":"ref39","unstructured":"ChemAxon [Internet]. 2013. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chemaxon.com\" xlink:type=\"simple\">http:\/\/www.chemaxon.com<\/ext-link>"},{"key":"ref40","unstructured":"GraphPad Software Inc. GraphPad Prism [Internet]. 2014. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.graphpad.com\/scientific-software\/prism\/\" xlink:type=\"simple\">http:\/\/www.graphpad.com\/scientific-software\/prism\/<\/ext-link>"},{"key":"ref41","unstructured":"Chemical Abstract Service. SciFinder [Internet]. 2014. 2013. Available from: scifinder.cas.org"},{"issue":"1\u20133","key":"ref42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting","volume":"46","author":"C a Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"e65994","DOI":"10.1371\/journal.pone.0065994","article-title":"Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening","volume":"8","author":"D Ger\u00f6","year":"2013","journal-title":"PLoS One [Internet]"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0162-3109(96)00122-1","article-title":"Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-\u03b1 by human mononuclear cells","volume":"35","author":"GS Madretsma","year":"1996","journal-title":"Immunopharmacology [Internet]"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/rheumatology\/keq213","article-title":"Methylprednisolone prevents tumour necrosis factor-alpha-dependent multinucleated giant cell formation","volume":"49","author":"HR Maltesen","year":"2010","journal-title":"Rheumatology (Oxford) [Internet]"},{"issue":"13","key":"ref46","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood-2005-04-1723","article-title":"Ligand-specific glucocorticoid receptor activation in human platelets","volume":"106","author":"L a Moraes","year":"2005","journal-title":"Blood [Internet]"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.bcp.2012.02.006","article-title":"Prednisolone exerts exquisite inhibitory properties on platelet functions","volume":"83","author":"E Liverani","year":"2012","journal-title":"Biochem Pharmacol [Internet]. Elsevier Inc."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-9255-5-11","article-title":"Anti-inflammatory effects of ciprofloxacin in S. aureus Newman induced nasal inflammation in vitro","volume":"5","author":"F Sachse","year":"2008","journal-title":"J Inflamm (Lond) [Internet]"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0039-128X(02)00024-7","article-title":"Effects of glucocorticoids on generation of reactive oxygen species in platelets","volume":"67","author":"BM Sanner","year":"2002","journal-title":"Steroids [Internet]"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/biof.1066","article-title":"Curcumin in inflammatory diseases [Internet]","author":"A Shehzad","year":"2013","journal-title":"BioFactors"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:47:53Z","timestamp":1748918873000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155325"}},"subtitle":[],"editor":[{"given":"Fulvio","family":"d'Acquisto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,10]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155325","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,10]]}}}